α-Tocopherol is the form of vitamin E with the highest biological value and is almost exclusively considered as vitamin E in feed and feed supplements. Because γ-tocopherol, the predominant form of vitamin E naturally present in chicken feed, is not considered as a source of vitamin E, its re-evaluation with newer methods might be important.
INTRODUCTION
Of all vitamin E isomers, RRR-α-tocopherol has been proven to be the most effective antioxidant in the situations of increased oxidative susceptibility and oxidative stress in vivo. In contrast to other forms of vitamin E, α-tocopherol is in liver preferentially recognized by α-tocopherol transfer protein, incorporated into very low-density lipoprotein (VLDL), and transferred to the tissues (Bramley et al., 2000) . Nevertheless, there are studies showing that high amounts of γ-tocopherol in the diet can prevent lipid peroxidation and protect against inflammation in vivo to the same extent as α-tocopherol (Chung et al., 2010) . Despite its poor retention, γ-tocopherol exerts such a high antioxidative capacity that if ingested in adequate C 2016 Poultry Science Association Inc. Received February 23, 2016 . Accepted July 11, 2016 Corresponding author: janez.salobir@bf.uni-lj.si amounts, it effectively protects against oxidative stress. γ-Tocopherol also exerts specific functions, which are less characteristic for α-tocopherol, e.g., detoxification of reactive nitrogen species (Cooney et al., 1995; Christen et al., 1997; Jiang and Ames, 2003) and antiinflammatory activity (Jiang et al., 2000; Kuo et al., 2008) . Clement and Bourre (1997) also proposed that the biopotency of α-tocopherol should be reevaluated when high levels of γ-tocopherol are present in the diet. In their study, dietary combination of α-and γ-tocopherol induced a greater increase of both forms in serum and tissues than α-tocopherol alone, suggesting a synergistic action between the two forms.
Not all functions of vitamin E can be ascribed to its antioxidant properties. It has been recognized that vitamin E functions as a gene expression and signal transduction regulator (Azzi et al., 2004) . It affects the expression of genes which encode the molecules involved in antioxidant action such as glutathione (Barella et al., 2004) , it enhances the expression of cytochrome P450 enzymes (Sontag and Parker, 2002) , down-regulates the expression of scavenger receptors CD36 (Ricciarelli et al., 2000) , and scavenger receptors-A (Teupser et al., 1999) and thus lowers the uptake of oxidized lipoproteins in macrophages. Furthermore, it decreases liver collagen m-RNA (Chojkier et al., 1998) , reduces the expression of genes involved in the key steps of de novo cholesterol biosynthesis (Valastyan et al., 2008) , and affects gene expression of transcription and cell cyclerelated molecules (De Pascale et al., 2006) and those connected to inflammation (Yoshikawa et al., 1998) . Most of the studies referring to gene expression focus on α-tocopherol. The changes in gene expression as a consequence of γ-tocopherol supplementation were mostly studied in cancer cell lines. γ-Tocopherol up-regulated peroxisome proliferator activated receptor (PPARγ) in colon cancer cell lines more significantly than α-tocopherol (Campbell et al., 2006) and down-regulated PPARγ in the ovine uterus similarly as α-tocopherol (Kasimanickam and Kasimanickam, 2011) .
The lack of research on γ-tocopherol in poultry and the fact that it is the most abundant form in some crops used in chicken nutrition (corn, soy), encouraged us to investigate if and to what extent this form of vitamin E contributes to the prevention from oxidative stress by itself or in combination with the α-homologue using newer analytical methods (e.g., global gene expression profiling). Different study designs, unequal dosages and combinations of tocopherols and the use of different species namely do not allow us to draw a general conclusion about the effect of different tocopherol forms on certain genes. Because the liver is the main organ, which regulates lipid and vitamin E metabolism it was of interest to investigate how specific forms of vitamin E (α-and γ-tocopherol) and their combination impact liver gene expression when the oxidative susceptibility of the organism is induced by high n-3 polyunsaturated fatty acids (PUFA) intake (linseed oil).
MATERIALS AND METHODS
After the approval of the Animal Ethics Committee of Veterinary Administration of the Republic of Slovenia, the experiment was performed in the experimental facilities of the Animal Science Department of the Biotechnical Faculty of the University of Ljubljana.
Animals and Dietary Treatments
Thirty-six one-day-old male broiler chickens ROSS 308 were housed in floor pens on litter bedding at a temperature of 30
• C (gradually decreasing as the animals grew) in conditions consisting of 16 h of light and 8 h of darkness for 30 days. At the beginning of the experiment, the animals were randomly divided into four groups and received a basic feed mixture formulated according to nutrition specifications for ROSS 308 broilers (2007). The diet contained 5% of purified linseed oil in order to increase oxidative stress in the organ- 1 Calculated to meet the mineral and vitamin requirements for the Ross 308: NaCl (3.2 g), CaCO 3 (13.3 g), MCaP (13.7 g), L-lysine 78.8 % (1.5 g), DL-methionine 98 % (2.3 g), threonine 98 % (0.5 g), Cu (16 mg), I (1.25 mg), Fe (40 mg), Mn (120 mg), Se (0.3 mg), Zn (100 mg); vitamins: A (10,000 IU), D3 (5,000 IU), K (3 mg), biotin H (0.2 mg), choline (1,500 mg), folic acid (1.75 mg), B1 (2 mg), B2 (6 mg), B3 (55 mg), B5 (13 mg), B6 (4 mg), B12 (0.02 mg), monesin sodium -coccidiostatic (0.6 g).
Cont -control group supplemented with 10 mg/kg α-tocopherol acetate; Tα -supplemented with RRR-α-tocopherol; Tγ -supplemented with RRR-γ-tocopherol; Tαγ -supplemented with equql amounts of RRR-α-tocopherol and RRR-γ-tocopherol.
ism. The chickens in the control group (Cont, N = 10) received a diet with 10 IU of vitamin E as all-rac-α-tocopheryl acetate (10 mg/kg) to meet NRC (1994) requirements in order to prevent vitamin E deficiency. Three groups were supplemented with either 67 mg/kg of RRR-α-tocopherol (Tα, N = 10), 67 mg/kg of RRR-γ-tocopherol (Tγ, N = 8), or 67 mg/kg of combination of both tocopherols (Tαγ, N = 8; 33.5 mg RRR-α-tocopherol + 33.5 mg RRR-γ-tocopherol) ( Table 1) . The feed mixtures for all groups were freshly prepared every 10 days at the department's feed mill, stored at −20
• C and thawed at room temperature on the day of feeding. Samples of every feed batch were obtained for chemical analysis, determination of fatty acid composition, and α-and γ-tocopherol content (Table 2) .
Water and feed were provided ad libitum. Live weight gain and feed consumption were recorded weekly and just before sacrifice. The chickens remained healthy during the experiment, there were no differences in body weight and feed consumption among treatment groups (data not shown). After 30 days of the treatment, the animals were euthanized by cervical dislocation and sacrificed. Whole blood and liver samples were collected for analysis.
Vitamin E Supplementation
For the purpose of knowing and maintaining the exact concentrations, vitamin E was removed from linseed oil using the deodorization process. The oil was mixed with 15% of diatomeae solum, shaken for 3 hours, centrifuged for 5 min at 2000 × g and stored at −20
• C. The RRR-α-tocopherol (T3634, Sigma-Aldrich, Seelze, Germany) and RRR-γ-tocopherol (T1782, SigmaAldrich, Seelze, Germany) were dissolved in linseed oil prior adding to the feed mixtures. Taking into account its bioactivity, the amount of added α-tocopherol (Naumann and Bässler, 1997) . The values are the means of two analyses per sample.
2 Only predominant fatty acids are listed, but the sums of saturated fatty acids (SFA), monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) are computed from all fatty acids analyzed.
Cont -control group supplemented with 10 mg/kg α-tocopherol acetate; Tα -supplemented with 67 mg/kg RRR-α-tocopherol (100 IU); Tγ -supplemented with 67 mg/kg RRR-γ-tocopherol. Tαγ -supplemented with 33.5 mg/kg of RRR-α-tocopherol (50 IU) and 33.5 mg/kg RRR-γ-tocopherol.
(67 mg/kg of RRR-α-tocopherol) equals 100 IU of vitamin E. RRR-γ-tocopherol was added in the same amount as RRR-α-tocopherol.
Sample Collection
Blood, plasma, and liver samples were adequately processed and stored at −70
• C until analysis. Liver samples for gene expression analysis were immediately frozen in liquid nitrogen and then, as with the other samples, kept at −70
• C.
RNA Extraction and Gene Expression Analysis
The stainless steel Bessman Tissue Pulveriser (Spectrum Europe, Breda, Netherlands) was used to pulverize nitrogen frozen liver tissue. The pulverized tissue was homogenized in TRI-reagent (T9424, Sigma-Aldrich, Seelze, Germany) with Ultra turrax T8 IKA (Labortechnik, Wasserburg, Germany). RNA was extracted by standard phenol-chloroform extraction. RNA integrity was checked by RNA Integrity Number (RIN) with Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA). RIN values for all samples ranged between 8.9 and 9.3 suggesting a high overall quality of extracted RNA.
The RNA samples of four birds per treatment group were selected for gene expression analysis. The commercial Affymetrix GeneChip Chicken Genome Array (900592, Affymetrix, Santa Clara, CA), which covers 32,773 transcripts corresponding to over 28,000 chicken genes was used. Probe sets on this array were designed with 11 oligonucleotide pairs to detect each transcript. The RNA preparation, hybridization and scanning were performed at ARK Genomics, Roslin Institute, University of Edinburgh, UK, following the standard protocol (Affymetrix GeneChip Expression Analysis Technical Manual). Following the scanning of the arrays, all raw data passed the quality control assessed by the Affymetrix Expression Console software. The procedures of further analyses of expression data are described in the section "Statistical analysis".
Microarray data are available in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-4507.
Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR)
The most differentially expressed genes from each of the important pathways affected by the treatment were selected for validation with the qRT-PCR. The same liver RNA samples were used as in the array experiment. Total RNA (1 μg) was treated with amplification grade DNase I, and reverse transcribed using the SuperScript VILO cDNA Synthesis Kit (Invitrogen, Carlsbad, CA). Real time quantitative PCR was performed on the LightCycler 480 detection system using LightCycler 480 SYBR Green I Master according to the manufacturer's instructions (Roche, Mannheim, Germany). Primers were designed using the Primer3 software (Rozen and Skaletsky, 2000) and validated for PCR efficiency. PCR was performed with the following PCR parameters: 95
• C for 10 min, then 95 • C for 10 s, 60
• C for 30 s, 72
• C for 5 s for 38 cycles, plus a dissociation step (60 to 95
• C). The relative expression ratios were calculated exactly as described ( Vandesompele et al., 2002) . Stably expressed genes RPL4, RPLP0, PPIB, and EIF2a were used as internal reference genes.
Fatty Acid Composition
Fatty acids in feed and liver samples were in situ transmethylated (Park and Goins, 1994) and fatty acid methyl esters (FAMEs) were extracted using hexane. Prior to the sample esterification, the C19:0 was added as an internal standard. For FAMEs separation Agilent 6890 GC, equipped with Omegawax 320 column (30 m × 0.32 mm i.d. × 0.25 μm, Supelco Inc., Bellefonte, PA) and FID detector, was used. Analytical results are excluded from the data presentation, as there were no differences among vitamin E suplemented groups.
Malondialdehyde Determination
The methodology of Wong et al. (1987) , modified by Chirico (1994) and Fukunaga et al. (1995) , was implemented to determine the concentrations of malondialdehyde (MDA) in blood plasma using HPLC. In order to determine the MDA concentrations in liver, a modified protocol of the methodology of Vilà et al. (2002) was used. Briefly, frozen liver samples were homogenized (Grindomix homogenizer, Retsch Gmbh & Co, Haan, Germany) and 0.3 g of the homogenized sample was mixed with 1.5 mL of 2.5% TCA (trichloroacetic acid) in Eppendorf microcentrifuge tubes, left for ten minutes and then centrifuged (15000 × g for 15 minutes at 4
• C). The supernatant (1 mL) was mixed with 1.5 mL of 0.6% TBA and heated at 90
• C for 60 minutes. After cooling, the samples were filtered through Millipore filters (pore size 0.22 μm) into vials. A Waters Alliance 2690 (Waters, Milford, MA) equipped with a Waters 474 scanning fluorescence detector was used to determine plasma and liver MDA. For the purpose of separation, a reversed-phase HPLC chromatography column (HyperClone 5u ODS (C 18 ) 120A, 4.6 × 150 mm; Phenomenex Inc., Torrance, CA) and C 18 ODS guard column (4 mm × 3 mm; Phenomenex Inc., Torrance, CA) were used. The mobile phase consisted of a 65% 50 mmol/L KH 2 PO 4 buffer (pH 6.9) and 35% methanol. The mobile phase rate was 1.0 mL/min. The results of the analysis were evaluated using the Millenium 32 Chromatography Manager program (Waters, Milford, MA).
Plasma Total Cholesterol and Triglyceride Concentration
Plasma concentrations of cholesterol and triglycerides were determined with an automated biochemical analyzer RX-Daytona using cholesterol CH 3810 and triglyceride TR 3823 kits (Randox, Crumlin, UK).
Determination of Vitamin E (α-, β-, γ -, and δ-Tocopherol)
Concentrations of vitamin E in feed, plasma and liver were measured according to the methodology of Abidi and Mounts (1997) and Rupérez et al. (2001) . Briefly, the samples were treated with ethanol and the tocopherols were extracted from the samples using hexane. Hexane phases were transferred into fresh tubes and carefully evaporated under a gentle stream of nitrogen; the residues were subsequently dissolved in ethanol. The samples were transferred to vials and analyzed by a reverse-phase HPLC (Waters Alliance 2690, Waters, Milford, MA) using a Luna 5u PFP(2) column (100A 250 × 4.6 mm; Phenomenex Inc., Torrance, CA). The mobile phase consisted of methanol, the mobile phase rate was 1.5 mL/min. In the results only α-and γ-tocopherol were of interest.
Statistical Analysis
Data normalization and statistical analysis of gene expression data (ANOVA) was carried out in Partek Genomics Suite (Partek Inc., St. Louis, MO). The genes with intensity fold change higher than 1.2 and concomitant significance P ≤ 0.05 were considered differentially expressed. For further bioinformatics analysis, the gene lists were uploaded into Qiagen's Ingenuity Pathways Analysis Software 9.0 (IPA; Ingenuity Systems, Redwood City, CA) to identify relationships, mechanisms, functions, and pathways of the genes which were differentially expressed among treatment groups.
Using IPAs network analysis tools, we tested which of the differentially expressed genes belong to the same network likely to be perturbed in the liver due to alphaand gamma-tocopherol treatments. By functional analysis option, the biological functions of our candidate genes were determined and functions that are expected to increase or decrease, given the observed gene expression changes in our experimental dataset, were predicted. The IPAs canonical pathways analysis was used to identify and rank the most significant canonical pathways across the entire dataset. The significance value for the canonical pathways was calculated by Fisher's exact right-tailed test and indicates the probability of association of molecules from your dataset with the canonical pathway by random chance alone. Most of the genes chosen for qRT-PCR verification showed a similar trend in the expression as in the microarray experiment, however due to the inter-individual variability and small sample size, some changes in expression did not meet statistical significance. We observed a very good correlation between the microarray experiment and the qRT-PCR (Figures 1, 2, and 3) .
For the analysis of all other parameters, the General Linear Models (GLM) procedure of the SAS/STAT module (SAS 8e, 2000; SAS Inc., Cary, NC) was used, with group being the main effect. Differences between groups were determined on the basis of the TukeyKramer multiple comparison test. Significance was considered to be established at P < 0.05. The results in the tables are presented as least square means (LS-means) ± SEM with P-values. For the statistical analysis of fatty acid percentages, the transformation of raw data with arcsine of square root for normalization was used.
RESULTS AND DISCUSSION
The Effect of α-and γ -Tocopherol and their Combination on the Oxidative Stress Parameters, Plasma, and Liver Vitamin E
Concentration and Liver Fatty Acid Composition
It is well documented that a high PUFA diet increases the risk of oxidative stress in the organism and is reflected in the fatty acid composition of the tissues Means within a row lacking a common superscript differ significantly. Upper-case letters represent significance of P ≤ 0.01; lower-case letters represent significance of P ≤ 0.05.
Cont -control group supplemented with 10 IU α-tocopherol acetate; Tα -supplemented with 67 mg/kg RRR-α-tocopherol (100 IU); Tγ -supplemented with 67 mg/kg RRR-γ-tocopherol. Tαγ -supplemented with 33.5 mg/kg of RRR-α-tocopherol (50 IU) and 33.5 mg/kg RRR-γ-tocopherol. (Lauridsen et al., 1997) . This was also observed in our study, where the proportion of PUFA in chicken liver was high in all treatment groups. On the other hand, vitamin E supplementation did not affect the liver fatty acid composition (data not shown).
Supplementation with α-tocopherol substantially increased α-tocopherol content in plasma and liver, but had no effect on the level of γ-tocopherol (Table 3) . In contrast to α-tocopherol, γ-tocopherol supplementation increased its plasma and liver concentrations to a much lesser extent. A 38-fold lower plasma and a 30-fold lower liver γ-tocopherol in Tγ were measured relative to α-tocopherol content in Tα (Table 3) . When both tocopherols were added together in equal amounts (Tαγ), plasma and liver α-tocopherol concentrations were half of the amount as in Tα (Table 3) , meaning that the degree of α-tocopherol retention was the same as when it was fed alone. Groups Tγ and Tαγ had equal levels of γ-tocopherol in plasma and liver although chickens in Tγ received twice as much dietary γ-tocopherol (Table 3 ). The same trend was observed in heart, fat, brain, breast, and thigh muscle samples (data not shown), suggesting that γ-tocopherol reached a threshold for tissue accumulation. Similar results were obtained in a rat study from Clément et al. (1995) where a 3.3-fold higher serum and a 5.9-fold higher liver concentrations of α-tocopherol than γ-tocopherol were determined. Clément and Bourre (1997) studied the effects of feeding vitamin-E-depleted rats with diets containing a constant amount of RRR-α-tocopherol (30 mg/kg) and varied amounts of RRR-γ-tocopherol (γ/α ratio ranging from 1 to 5) on concentrations of α-and γ-tocopherol in serum and different tissues. The results obtained with diets enriched with increasing levels of RRR-γ-tocopherol showed that the higher the γ/α ratio, the more α-and γ-tocopherol concentrations increased in all tissues. This is not in total agreement with our results, where levels of γ-tocopherol in groups Tγ and Tαγ did not differ, although chickens in Tγ received twice as much γ-tocopherol. The reason may be in the difference between mammal and chicken fat metabolism. In contrast to mammals where the absorbed tocopherols are bound to chylomicrons and circulate in blood, in chickens the absorbed vitamin E is bound to portomicrons and transferred directly to the liver (Krogdahl, 1985) , where α-tocopherol is preferentially incorporated to lipoproteins while γ-tocopherol is metabolized and excreted via bile and urine (Jiang et al., 2001) .
The role of α-tocopherol in the prevention of oxidative stress in chickens has been extensively investigated (Lauridsen et al., 1997; Cortinas et al., 2005; Voljč et al., 2011) . The role of γ-tocopherol in chickens was previously studied in relation to the specific health states, e.g., its activity relative to α-tocopherol in the prevention of exudative diathesis and muscle dystrophy (Bieri and Poukka Evarts, 1974) and its effect in the condition of pulmonary hypertension syndrome (Bottje et al., 1997) . To date however, there is still a lack of understanding of the role of γ-tocopherol and its interaction with α-tocopherol in chickens from the aspect of oxidative stress. In our research, plasma MDA levels decreased in Tα and Tαγ, only. On the other hand, in liver only the combination of both tocopherols was able to substantially lower the MDA concentration (Table 3 ). This indicates a synergistic effect of α-and γ-tocopherol which may potentially contribute to positive effects in combating oxidative stress in liver. The sole addition of γ-tocopherol was not able to prevent the oxidation of plasma lipids, while in liver it was able to reduce MDA concentration to the same level as α-tocopherol (Table 3 ). The antioxidant activity of γ-tocopherol tends to be higher in liver than in plasma, possibly reflecting the differences between mammal and bird fat metabolism as already mentioned. γ-tocopherol's antioxidant activity has been otherwise well described in the manner of its ability to quench reactive nitrogen species (Cooney et al., 1995; Christen et al., 1997) , however the studies investigating its function in the prevention of reactive oxygen species (ROS) are scarce (Li et al., 1999; Chung et al., 2010) . In contrast to our study, in the above mentioned studies γ-tocopherol significantly decreased oxidative stress biomarkers. The discrepancy between our results and aforementioned studies can be assigned to the large differences in the amount of γ-tocopherol supplemented to the animals (10-fold difference) and to the animal models used in the experiments (rats and mice versus chickens). Regarding the combination of α-and γ-tocopherol in the prevention of oxidative stress, its efficiency was proposed in a study from Devaraj et al. (2008) , where the supplementation of subjects with metabolic syndrome with 800 mg of α-or γ-tocopherol alone and in combination reduced plasma MDA/HNE (4-hydroxynonenal) levels and reduced lipid peroxides compared to the placebo.
The Effect of Vitamin E Supplementation on Global Gene Expression
Compared with unsupplemented control group (P ≤ 0.05, cut-off fold change >1.2), the expression levels of 594 annotated genes were altered in chickens fed α-tocopherol. In group fed γ-tocopherol, 888 annotated genes were differentially expressed and in Tαγ fed group 1,127 annotated genes were differentially expressed. One hundred and twenty-nine differentially expressed annotated genes (83 up-regulated, 46 down-regulated) were common to all three groups supplemented with vitamin E (compared to Cont). These genes are encoding molecules involved in lipid metabolism (N = 13), small molecule biochemistry (N = 24), molecular transport (N = 22), carbohydrate metabolism (N = 12), and gene expression (N = 22) (Ingenuity pathway analysis 9.0; 5 most represented groups, P ≤ 0.05). The most strongly up-and downregulated genes in the three vitamin E supplemented groups in comparison to Cont are presented in Table 4 . Ingenuity pathway analysis (Tables 4-7) showed pronounced changes in the expression of genes involved in various pathways and functions. We specifically focused on the functions and pathways shown to be the most significantly affected by specific vitamin E isomer (Ingenuity pathway analysis) and to the ones that were in the special interest to the study (oxidative stress, immune response).
The Effect of Vitamin E Supplementation on Genes Connected to Lipid and Cholesterol Metabolism
Down-regulation of several genes in pathways of sterol and cholesterol biosynthesis was detected in the group supplemented with 100 IU of α-tocopherol (Table 5 ). The study from Valastyan et al. (2008) reported that ten genes, which were encoding the key proteins involved in cholesterol biosynthesis, were also negatively affected by α-tocopherol treatment in human HepG2 C3A cells. These genes shared a sequence, known as sterol response element, which is the binding site for transcription factor sterol regulatory element-binding protein (SREBP-2). Data from the rat experiment and an in vivo study (König et al., 2007) also indicate that PPARα activation lowers cholesterol concentration by reducing the abundance of SREBP-2, consequently resulting in diminished expression of SREBP-2 target genes. In our study, PPARa was upregulated in all three supplemented groups, while the expression of SREBP2 was down-regulated only in Tα (Table 5) . Salt inducible kinase (SIK1) which represses steroidogenic gene transcription by inhibiting the efficient operation of the cyclic AMP response element (CRE)-binding protein (Okamoto et al., 2004) was upregulated in all three groups with tocopherol supplement (Table 5) . Genes encoding proteins which are known to mediate the redistribution of cholesteryl esters, triglycerides, and phospholipids between plasma lipoproteins, were also affected by α-tocopherol treatment, for instance, cholesteryl ester transfer protein (CETP) was 1.5-fold down-regulated. This protein has been suggested to enhance reverse cholesterol transport, the pathway in which the cholesterol from peripheral tissues is transported to the liver for elimination via bile (Barter et al., 2003) . Simultaneously, angiopoietin like 3 (ANGPTL3), the gene encoding the protein, which inhibits the lipoprotein lipase activity (Li, 2006) and thus limits cholesterol release Cont (N = 4) -control group supplemented with 10 IU α-tocopherol acetate; Tα (N = 4) -supplemented with 67 mg/kg RRR-α-tocopherol (100 IU); Tγ (N = 4) -supplemented with 67 mg/kg RRR-γ-tocopherol. Tαγ (N = 4) -supplemented with 33.5 mg/kg of RRR-α-tocopherol (50 IU) and 33.5 mg/kg RRR-γ-tocopherol.
* P ≤ 0.05; * * P ≤ 0.01.
from low-density lipoprotein (LDL), was also downregulated with the addition of α-tocopherol (2.6-fold, P = 0.02, data not shown). The reduced reverse cholesterol transport may be the reason for the observed increased plasma cholesterol concentration in groups supplemented with α-tocopherol ( Table 3) . The Shin and Osborne mouse study (2003) reported that a link between thyroid hormones (TH) and cholesterol metabolism was based on the direct effect of TH on SREBP2 expression. The connection of these two metabolic pathways has also been observed in our study as the changes in the expression of 5-deioidinase type 2 (DIO2) and 5-deiodinase type 3 (DIO3) were significant. The member of TH -L-thyroxine (T4) is converted to the active hormone (T3) by two isomerases, the 5-deioidinase type 1 (DIO 1 ) and the DIO 2 . Another type of deiodinases, DIO3 inactivates the pro-hormone T4 and also eliminates the active T3 form (Köhrle, 1999) . The expression of DIO2 was significantly downregulated in groups supplemented with vitamin E while the expression of DIO 3 was up-regulated. As the expression of SREBP2 and other genes involved in cholesterol biosynthesis, was lower in the group Tα compared to Cont, the influence of thyroid hormones on cholesterol metabolism, mediated by SREBP-2, could be proposed. Future studies of this possible regulatory link should examine also the protein levels and posttranslational modifications of SREBP-2 as this has been recognised as the major molecular event in regulating its downstream target genes. However, some reports in rodent and cell models (e.g., Sato et al., 1996) and also in the chicken provide evidence that SREBP-2 is not always regulated only post-translationally by proteolytic activation of the precursor protein but also transcriptionally by itself and other factors. For example, developmental processes (Hu et al., 2012) in the chicken co-ordinately affected hepatic SREPB2 mRNA and its protein levels, feeding regime post hatch significantly affected SREPB2 mRNA transcription (Richards et al., 2010) , and agonists of liver X receptors (LXRs) upregulated SREPB2 mRNA as well as cholesterol synthesis and uptake in the chicken hepatocytes (Sato and Kamada., 2011) . Therefore, our result of decreased SREPB2 mRNA in the Tα suggests possible regulation of this gene by α-tocopherol. This regulation and a possible link with the thyroid hormone regulation should be examined in future using a more targeted experimental design.
Thyroid hormones are also involved in lipid metabolism. The study of Park et al. (1995) showed an increase in carnitine palmitoyltransferase 1A (CPT1α) expression in hyperthyroid state. In our study, the expression of CPT1α was increased in Tγ in Tαγ, which indicates increased transfer of fatty acids trough mitochondrial membrane and their increased oxidation. The increase of CPT1α expression in mentioned groups coincides with the increase of DIO3 and decrease of DIO2 expression in Tγ in Tαγ fed chickens (Table 5) .
Pyruvate dehydrogenase kinase isozyme 4 (PDK4) plays a key role in gating carbohydrate catabolism and switching to lipid metabolism. The importance of vitamin E supplementation in this manner can be suggested as activation of PDK4 was observed in all three vitamin E supplemented groups (Table 5 ). The role of vitamin E in sparing glucose can also be supported by the upregulation of PCK1 in all three vitamin E supplemented groups (4.5-, 5.8-, and 8.9-fold in Tα, Tγ, and Tαγ, respectively). Promotion of the expression of 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) by the addition of vitamin E confirms a switch of metabolism in favor of fatty acid oxidation (Table 5) as this gene encodes a ketogenic enzyme. In support of this result is a study by Désert et al. (2008) , where this gene was highly up-regulated in chickens after 16 hours of fasting.
Regarding differentially expressed liver genes connected to lipid and cholesterol metabolism, we can Cont (N = 4) -control group supplemented with 10 IU α-tocopherol acetate; Tα (N = 4) -supplemented with 67 mg/kg RRR-α-tocopherol (100 IU); Tγ (N = 4) -supplemented with 67 mg/kg RRR-γ-tocopherol. Tαγ (N = 4) -supplemented with 33.5 mg/kg of RRR-α-tocopherol (50 IU) and 33.5 mg/kg RRR-γ-tocopherol.
summarize that vitamin E has a profound role in this manner. The mitochondrial fat oxidation seems to be increased with the addition of both α-and γ-tocopherol alone and in combination, while cholesterol metabolism is affected mostly by α-tocopherol. According to the differences in gene expression, along with the supplementation of α-tocopherol poorer cholesterol synthesis is expected.
The Influence of Vitamin E on the Transcription of Genes Connected to Oxidative Stress
All three tocopherol supplementations significantly increased the expression of coenzyme Q10 homolog B (S. cerevisiae) gene (COQ10B), with γ-tocopherol and the combination of both tocopherols being more effective than α-tocopherol (Table 6 ). COQ10 homolog B is a conserved CoQ-binding protein that is essential for the proper function of the electron transfer system, possibly by assisting the transfer of CoQ from one site to another in the mitochondrial membranes of eukaryotes (Cui and Kawamukai, 2009) . COQ10B expression was lower in Cont group, which can be explained by the low antioxidant supplementation in this group. Hypotheticaly, the animals could have used all of the available CoQ10 for protection against oxidative stress and the synthesis of CoQ10 was not sufficient to stimulate the expression of COQ10B.
Nuclear factor erythroid 2-related factor (NFE2L2/NRF2) has been proven to be the main transcription factor regulating the expression of genes which protein products are involved in detoxification and elimination of reactive oxygen species (Nguyen et al., 2009) . Nuclear transition of NFE2L2 and its binding to antioxidant response element is regulated in part by PIK3R1 (Kang et al., 2005) . We observed a lower expression of PIK3R1 in groups supplemented with γ-tocopherol and the tocopherol combination, while the intensity of NFE2L2 expression decreased only in Tαγ group (Table 6) .
Furthermore, gene encoding activating transcription factor 4 (ATF4), a dimerization partner of NFE2L2 was down-regulated with the combination of both tocopherol isomers (Tαγ) ( Table 6 ). ATF4 is known to induce heme oxygenase (HMOX1) expression and to promote the resistance to oxidative stress (He et al., 2001) . HMOX-1 was also down-regulated in Tγ and Tαγ for 1.3-fold (P < 0.01) in comparison to Cont (Table 6) . We also observed a change in the expression of glutathione S-transferase alpha 3 (GSTA3) and glutathione S-transferase mu 2 (GSTM2) with the addition of α-tocopherol (Tα) ( Table 6 ). In our study vitamin E also lowered the expression of hepatocyte nuclear factor 4α (HNF4α) ( Table 6 ), confirming the involvement of this transcription factor in the mechanism responsible for the alleviation of oxidative stress. In previous study on Caco-2 cells, inactivation of HNF4α resulted in increased oxidative stress as demonstrated by higher levels of MDA and conjugated dienes, by reduced secondary endogenous antioxidants (catalase, glutathione peroxidase, and heme oxygenase-1) and by lower protein expression of NFE2L2/NRF2 (Marcil et al., 2010) . Therefore, all vitamin E groups exhibited a favorable expression profile of liver genes involved in oxidative stress defence. It is important to document that expression profiles of some genes involved in oxidative stress were similar between γ-and α-tocopherol, while there was a marked difference between the two isomers in the expression of other genes (e.g., genes of NFE2L2/NRF2 pathway; Table 6 ).
The Effect of Vitamin E on the Transcription of Genes Involved in Immune and Inflammatory Processes -the Link Between Immunity and Oxidative Stress
In a study by Xiao et al. (2011) the regulation of genes involved in immune and inflammatory processes confirmed the role of α-tocopherol in immune and inflammatory processes in chickens. In our study, such an effect of vitamin E was more pronounced in both groups receiving γ-tocopherol supplementation (Tγ and Tαγ). A series of the interferon regulatory factors (IRFs), the proteins which regulate the transcription of interferons (IFN), was differentially expressed in Tγ and some of them in Tαγ as well (Table 7) . IRF1 was down-regulated in Tγ (Table 7) and IRF2 was in Tγ and Tαγ up-regulated (Table 7) . While IRF-1 functions as a transcriptional activator, IRF-2 represses the function of IRF-1 (Tanaka et al., 1993; Harada et al., 1994) . IRF4, encoding the protein which participates in the negative-feedback regulation of TLR signaling (Negishi et al., 2005) was in Tγ also down-regulated (Table 7) . IRF8, whose protein is induced in macrophages by IFN-γ and contributes to macrophage functions (Kuwata et al., 2002) , was down-regulated in Tγ by 1.8-fold (P = 0.03). None of the listed genes was differentially expressed in Tα. Down-regulation of lymphocyte antigen 96 encoding gene (LY96), toll-like receptor 2 (TLR2) and leukocyte ribonuclease A-2 (RSFR) in Tγ and Tαγ was detected (Table 7) . These results provide further support to a conclusion that γ-tocopherol is able to elicit beneficial gene expression profile of liver immune genes in response to induced oxidative stress by linseed oil. In future experiments it would be interesting to determine in which liver resident cell types (e.g., hepatocytes, Kupfer cells etc.) or infiltrating immune cells γ-tocopherol induces these changes and by which direct or indirect mechanism. The activity of mitogen-activated protein kinases phosphatases, also named dual specificity phosphatases (DUSP) is diminished by oxidation, as these phosphatases are the prominent targets of ROS. Gene encoding DUSP16 (dual specificity phosphatase 16, also MKP7) was significantly up-regulated in all three vitamin E supplemented groups (Table 7) .
The differential expression of genes encoding follistatin (FST) and activin A (INHBA) also confirms the involvement of vitamin E in inflammatory processes. FST was significantly up-regulated in Tγ and Tαγ (Table 7) , while INHBA was down-regulated for 1.6-fold (P = 0.08) and 1.8-fold (P < 0.05) in Tγ and Tαγ, respectively. As summarized in review articles by Jones et al. (2004) and de Kretser et al. (2012) , the expression of activin A is stimulated by proinflammatory cytokines, while FST is a potent inhibitor of activin A function. In all three vitamin E supplemented groups the up-regulation of amino oxidase, copper-containing-3 (AOC-3; Table 7 ) also confirmed the role of vitamin E in inflammatory processes. AOC-3 being a non classical ectoenzyme and an adhesion molecule that is highly expressed in the liver promotes leukocyte adhesion in vivo and also exerts functional effects in organs remote from the site of origin (Lalor et al., 2007) .
The inducible cAMP early repressor (ICER), which belongs to the (CRE)-binding proteinand CRE modulator family, was up-regulated in all three vitamin E supplemented groups. The effect was the mostly pronounced in Tαγ (Table 7) . ICER is a dominant negative regulator of the cAMP-dependent protein kinase A pathway of signal transduction (Molina et al., 1993) and plays an important role in T cell activation (Bodor et al., 2001) . In their study, transgenic thymocytes overexpressing ICER exhibited reduced levels of IL-2 and interferon (IFN)-γ and failed to express the macrophage inflammatory protein (MIP)-1α and MIP-1β genes. Besides, splenic T cells from ICER-transgenic mice showed a defect in proliferation and lacked a mixed lymphocyte reaction response. Taken together, these results suggest that γ-tocopherol and its combination with α-tocopherol are involved in the regulation of genes encoding pro-inflammatory cytokines and chemokines.
In conclusion, supplementing chickens with α-and γ-tocopherol, and their combination in case of linseed oilinduced oxidative stress resulted in diverse responses as assessed by plasma and liver metabolome and transcriptome analysis. The reduced plasma MDA levels illustrate the efficiency of α-tocopherol and the combination of tocopherols in the prevention of oxidative stress. This is most probably the consequence of the preferential retention of α-tocopherol in the organism. In liver, the synergistic effect of the combination of α-and γ-tocopherol may be proposed. Liver gene expression analysis showed an important role of α-tocopherol in down-regulating the transcription of cholesterolic genes through the influence on thyroid hormones. Differential expression of various genes involved in fatty acid oxidation with the addition of both separate tocopherols and their combination indicates a switch in the metabolism to improved fat oxidation and glucose sparing. According to the differential gene expression in groups supplemented with γ-Tocopherol, this isomer is also important in the prevention of oxidative stress. The results also indicate a pronounced effect of γ-tocopherol and the combination of α-and γ-tocopherol on the expression of genes being important in the regulation of immune and inflammatory processes and thus provide a completely new insight into the underestimated role of γ-tocopherol in chickens. Its role from such perspective should be further evaluated and additionally supported by using different metabolomic analyses, which would confirm its beneficial role.
